Date Initiated by Firm | January 29, 2020 |
Date Posted | February 14, 2020 |
Recall Status1 |
Terminated 3 on April 16, 2024 |
Recall Number | Z-1131-2020 |
Recall Event ID |
84826 |
510(K)Number | K103153 K110134 |
Product Classification |
Catheters, transluminal coronary angioplasty, percutaneous - Product Code LOX
|
Product | NC TREK Coronary Dilatation Catheter, REF 1012453-20 Rx Only, NC TREK RX 4.00 X 20MM BDC
The NC TREK RX Coronary Dilatation Catheter is indicated for: a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, for the purpose of improving myocardial perfusion b) balloon dilatation of a coronary artery occlusion, for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction c) balloon dilatation of a stent after implantation (balloon models 2.00 mm 5.00 mm only) |
Code Information |
Device Identifier/GTIN: 08717648152085 Part Number: 1012453-20 Lot Numbers: 90727G1 91004G1 90830G1 91028G1 90923G1 |
Recalling Firm/ Manufacturer |
Abbott Vascular 26531 Ynez Rd D-03Q3, AP52-1 Temecula CA 92591-4630
|
For Additional Information Contact | Alicia Swanson 408-845-3427 |
Manufacturer Reason for Recall | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
FDA Determined Cause 2 | Process change control |
Action | On 01/29/2020, the firm field personnel and Affiliates directly contacted the first customers beyond the firm's control via phone, email, or personal visit to facilitate rapid notification. The "URGENT MEDICAL DEVICE RECALL" Notification informed customers that specific lots of its Coronary Dilatation Catheters with diameters of 4.0 mm, 4.5 mm, and 5.0 mm may exhibit difficulty or inability to deflate the balloon due to weaker material proximal to the balloon bond resulting from excess heat exposure during manufacturing, and the potential risks with the use of the affected products include air embolism, thrombosis, myocardial infarction and additional intervention.
Healthcare Professionals will be instructed to:
" Reference the attached list of affected part numbers and lot numbers
" Immediately stop using affected devices from these lots
" Review your inventory, complete and return the attached Effectiveness
Check Form
" Return all unused affected product to Abbott
" Share this notification with other relevant personnel in their organization
The action the Recalling Firm is taking:
* Stopped shipping affected lots
* Will implement appropriate corrective actions to ensure product performance
* Field Representatives can assist in identifying and returning affected devices
* Will work with customers to replace returned units with similar devices, pending availability.
For any questions, contact Customer Service Department at (800) 227-9902. |
Quantity in Commerce | Total 39687 NC TREK units (13891 US and 25796 OUS) |
Distribution | Worldwide Distribution: US (Nation-wide) and OUS (countries of):
Algeria Jordan
Argentina Korea
Armenia Kuwait
Aruba Lebanon
Australia Malaysia
Austria, Mauritius
Bahrain Mexico
Bangladesh Morocco
Belgium Netherlands
Brazil New Zealand
Brunei Norway
Bulgaria Oman
Canada Pakistan
Chile Panama
China Peru
Colombia Poland
Costa Rica Portugal
Croatia R¿union
Cyprus Romania
Czech Republic Russian Federation
Denmark Saudi Arabia
Dominican Republic Singapore
Egypt Slovakia
Estonia Slovenia
Finland South Africa
France Spain
Germany Sri Lanka
Greece State of Palestine
Hong Kong Sweden
Hungary Switzerland
Iceland Taiwan, Province of China
India Thailand
Indonesia Tunisia
Iran Turkey
Iraq Ukraine
Ireland United Arab Emirates
Israel United Kingdom
Italy Uruguay
Japan Viet Nam |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = LOX
|